CasNo.163222-33-1,Ezetimibe,High purity,Ezetimibe(163222-33-1) Suppliers

0	Negotiable

Min.Order :0
Purity: 99%min

Keywords

Ezetimibe 163222-33-1 Zetia;

Quick Details

Appearance:see the specification
Application:pharmaceutical intermediate
PackAge:1kg/bag, 10kg/drum, 25kg/drum(on requests)
ProductionCapacity:
Storage:cool,dry,sealed and ventilated
Transportation:

Superiority:

Product Name:Ezetimibe;
Alice:(3-Methyloxetan-3-yl)methanol;
3-Methyl-3-oxethanemethanol;
(3-Methyl-oxetan-3-yl)-methanol;
3-methyl-3-(hydroxy-methyl)-oxetane;
3-Hydroxymethyl-3-Methyloxetane;
3-methyl-3-oxetanyl-methyl alcohol;
3-Methyl-3-oxetanemethanol;
2-(Hydroxymethyl)-2-methyl-1,3-epoxypropane;
(3-Methyl-3-oxetanyl)methanol;
(3-methyloxetan-3-yl)methan-1-ol;
3-(Hydroxymethyl)-3-methyloxetane;;
CAS:3143-02-0;
Moleculer formula:C24H21F2NO3;
Moleculer weight:409.43;
Apperance:see the specification;
Purity:99.0%min;
Usage:Pharmaceutial intermediate;It is a medicine used to lower serum cholesterol concentration. Its mechanism of action is to inhibit the absorption of cholesterol in the small intestine. When the patient is intolerant to other anti-hyperlipidemia drugs, ezetimibe can be used alone or in combination with statins when they cannot effectively control blood lipids. In some major clinical medical guidelines, ezetimibe is recommended as the recommended second-line treatment when patients are intolerant to statins, or when statins alone cannot effectively reduce LDL. But the American Heart Association (AHA) and American College of Cardiovascular (ACC) do not recommend this

Details:

Product Name:Ezetimibe;
Alice:(3-Methyloxetan-3-yl)methanol;
3-Methyl-3-oxethanemethanol;
(3-Methyl-oxetan-3-yl)-methanol;
3-methyl-3-(hydroxy-methyl)-oxetane;
3-Hydroxymethyl-3-Methyloxetane;
3-methyl-3-oxetanyl-methyl alcohol;
3-Methyl-3-oxetanemethanol;
2-(Hydroxymethyl)-2-methyl-1,3-epoxypropane;
(3-Methyl-3-oxetanyl)methanol;
(3-methyloxetan-3-yl)methan-1-ol;
3-(Hydroxymethyl)-3-methyloxetane;;
CAS:3143-02-0;
Moleculer formula:C24H21F2NO3;
Moleculer weight:409.43;
Apperance:see the specification;
Purity:99.0%min;
Usage:Pharmaceutial intermediate;It is a medicine used to lower serum cholesterol concentration. Its mechanism of action is to inhibit the absorption of cholesterol in the small intestine. When the patient is intolerant to other anti-hyperlipidemia drugs, ezetimibe can be used alone or in combination with statins when they cannot effectively control blood lipids. In some major clinical medical guidelines, ezetimibe is recommended as the recommended second-line treatment when patients are intolerant to statins, or when statins alone cannot effectively reduce LDL. But the American Heart Association (AHA) and American College of Cardiovascular (ACC) do not recommend this